Polydeoxyribonucleotide (PDRN) restores blood flow in an experimental model of peripheral artery occlusive disease  Alessandra Bitto, MD, Francesca Polito,

Slides:



Advertisements
Similar presentations
Therapeutic angiogenesis: A comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin  Todd K. Rosengart, MD, Kurt.
Advertisements

Vascular endothelial growth factor-C derived from CD11b+ cells induces therapeutic improvements in a murine model of hind limb ischemia  Go Kuwahara,
Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: Roles of endothelial nitric oxide synthase and endothelial.
Angiogenic properties of sustained release platelet-rich plasma: Characterization in-vitro and in the ischemic hind limb of the mouse  Shyamal Chandra.
Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice  Junji Moriya, MD, PhD, Xiumin Wu, PhD, Jose Zavala-Solorio,
Adeno-associated virus serotype 9-mediated overexpression of extracellular superoxide dismutase improves recovery from surgical hind-limb ischemia in.
Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease  Marc Husmann, MD,
In vivo electroporation of constitutively expressed HIF-1α plasmid DNA improves neovascularization in a mouse model of limb ischemia  Geoffrey O. Ouma,
Ulka Sachdev, MD, Xiangdong Cui, MS, Edith Tzeng, MD 
Elevation of hemopexin-like fragment of matrix metalloproteinase-2 tissue levels inhibits ischemic wound healing and angiogenesis  April E. Nedeau, MD,
The therapeutic effect of vascular endothelial growth factor gene- or heme oxygenase-1 gene-modified endothelial progenitor cells on neovascularization.
Endogenous superoxide dismutase activation by oral administration of riboflavin reduces abdominal aortic aneurysm formation in rats  Zhenhai Yu, MD, Keisuke.
An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb.
Therapeutic distant organ effects of regional hypothermia during mesenteric ischemia- reperfusion injury  Rachel J. Santora, MD, Mihaela L. Lie, MD, Dmitry.
Gale Tang, MD, David N. Charo, Rong Wang, PhD, Israel F
VCAM-1 siRNA reduces neointimal formation after surgical mechanical injury of the rat carotid artery  Yanming Qu, MD, Xiangen Shi, MD, Hongwei Zhang,
Angiogenic properties of human placenta-derived adherent cells and efficacy in hindlimb ischemia  Aleksandar Francki, PhD, Kristen Labazzo, PhD, Shuyang.
Repetitive progressive thermal preconditioning hinders thrombosis by reinforcing phosphatidylinositol 3-kinase/Akt-dependent heat-shock protein/endothelial.
High-mobility-group box protein 1 A box reduces development of sodium laurate- induced thromboangiitis obliterans in rats  Xiangqian Kong, MD, Hai Yuan,
Jeanwan Kang, MD, Hassan Albadawi, MD, Virendra I. Patel, MD, Thomas A
Robert A. Brenes, MD, Caroline C
Polydeoxyribonucleotide restores blood flow in an experimental model of ischemic skin flaps  Francesca Polito, PhD, Alessandra Bitto, MD, PhD, Mariarosaria.
Ethyl pyruvate modulates delayed paralysis following thoracic aortic ischemia reperfusion in mice  Bao-Ngoc Nguyen, MD, Hassan Albadawi, MD, Rahmi Oklu,
Combination of stromal-derived factor-1α and vascular endothelial growth factor gene- modified endothelial progenitor cells is more effective for ischemic.
Angiogenesis in liver disease
Ryan M. McEnaney, MD, Ankur Shukla, MD, Michael C
Ulka Sachdev, MD, Xiangdong Cui, MS, Edith Tzeng, MD 
The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemia  Gale L. Tang,
Volume 65, Issue 5, Pages (May 2004)
Evidence for markers of hypoxia and apoptosis in explanted human carotid atherosclerotic plaques  Alessandra Bitto, MD, Giovanni De Caridi, MD, Francesca.
Tetramethylpyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia-reperfusion injury  Lihong Fan, MD, Kunzheng.
Cellular and molecular mechanism regulating blood flow recovery in acute versus gradual femoral artery occlusion are distinct in the mouse  Yagai Yang,
Metformin stimulates ischemia-induced revascularization through an eNOS dependent pathway in the ischemic hindlimb mice model  Noriko Takahashi, MD, Rei.
Simvastatin pretreatment enhances ischemia-induced neovascularization and blood flow recovery in streptozotocin-treated mice  Po-Hsun Huang, MD, PhD,
Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit.
Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,
Endothelial nitric oxide synthase affects both early and late collateral arterial adaptation and blood flow recovery after induction of hind limb ischemia.
Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation  Akira Marui, MD, Akihiro.
Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target.
Recanalization of arterial thrombus, and inhibition with β-radiation in a new murine carotid occlusion model: mRNA expression of angiopoietins, metalloproteinases,
Therapeutic site selection is important for the successful development of collateral vessels  Ayako Nishiyama, MD, PhD, Hiroyuki Koyama, MD, PhD, Tetsuro.
Vascular permeability effect of adenovirus-mediated vascular endothelial growth factor gene transfer to the rabbit and rat skeletal muscle  Lioubov Poliakova,
Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion 
Efficacy of fragmin/protamine microparticles containing fibroblast growth factor-2 (F/P MPs/FGF-2) to induce collateral vessels in a rabbit model of hindlimb.
Biochemically engineered stromal cell-derived factor 1-alpha analog increases perfusion in the ischemic hind limb  Bryan B. Edwards, BE, Alexander S.
Therapeutic angiogenesis: A comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin  Todd K. Rosengart, MD, Kurt.
Tormod S. Westvik, MD, Tamara N
Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: Roles of endothelial nitric oxide synthase and endothelial.
Dose-dependent neuroprotection of delta-opioid peptide [D-Ala2, D-Leu5] enkephalin on spinal cord ischemia-reperfusion injury by regional perfusion into.
Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis  Masayuki Kubo, PhD, Tao-Sheng Li, MD, PhD, Takahiro.
Subacute limb ischemia induces skeletal muscle injury in genetically susceptible mice independent of vascular density  Joseph M. McClung, PhD, Timothy.
Hong T. Hua, MD, Hassan Al-Badawi, MD, Fateh Entabi, MD, Michael C
Comparison of the vascular responses to balloon-expandable stenting in the coronary and peripheral circulations: Long-term results in an animal model.
Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques  Benjamin J. Dunmore, PhD, Mark J. McCarthy,
Ex vivo gene delivery of ephrin-B2 induces development of functional collateral vessels in a rabbit model of hind limb ischemia  Masatake Katsu, MD, Hiroyuki.
Volume 16, Issue 12, Pages (December 2008)
Ischemic preconditioning ameliorates spinal cord ischemia-reperfusion injury by triggering autoregulation  Cheng-Loong Liang, MD, Kang Lu, MD, PhD, Po-Chou.
Up-regulation of vascular endothelial growth factor mrna and angiogenesis after transmyocardial laser revascularization  Keith A Horvath, MD, Elaine Chiu,
Autophagy-mediated stress response in motor neuron after transient ischemia in rabbits  Hironori Baba, MD, Masahiro Sakurai, MD, PhD, Koji Abe, MD, PhD,
Todd R. Vogel, MD, MPH, Robin L. Kruse, PhD 
Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia  Steven.
Appropriate control of ex vivo gene therapy delivering basic fibroblast growth factor promotes successful and safe development of collateral vessels in.
Activation of adenosine A2A receptors by polydeoxyribonucleotide increases vascular endothelial growth factor and protects against testicular damage induced.
Overexpression of endothelial nitric oxide synthase increases skeletal muscle blood flow and oxygenation in severe rat hind limb ischemia  Lucy S Brevetti,
Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: Roles of endothelial nitric oxide synthase and endothelial.
Vascular endothelial cell growth factor and fibroblast growth factor 2 expression in patients with critical limb ischemia  Ulrika Palmer-Kazen, MD, David.
Volume 65, Issue 5, Pages (May 2004)
Volume 69, Issue 11, Pages (June 2006)
Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats  Shen-Kou Tsai, MD, PhD, Li-Man Hung, PhD,
Prospective randomized study evaluating an absorbable cyanoacrylate for use in vascular reconstructions  Alan B. Lumsden, MD, Eugene R. Heyman, PhD  Journal.
Presentation transcript:

Polydeoxyribonucleotide (PDRN) restores blood flow in an experimental model of peripheral artery occlusive disease  Alessandra Bitto, MD, Francesca Polito, PhD, Domenica Altavilla, PhD, Letteria Minutoli, MD, Alba Migliorato, PhD, Francesco Squadrito, MD  Journal of Vascular Surgery  Volume 48, Issue 5, Pages 1292-1300 (November 2008) DOI: 10.1016/j.jvs.2008.06.041 Copyright © 2008 The Society for Vascular Surgery Terms and Conditions

Fig 1 A, Blood flow evaluated by laser Doppler at 10 minutes, and at 7, 14, and 21 days after hind limb ischemia (HLI) in the various treatment groups. Rats were administered the vehicle or intraperitoneal polydeoxyribonucleotide (PDRN), at 2, 4, 8, or 16 mg/kg daily, starting immediately after surgery. PDRN (8 and 16 mg/kg) restored blood flow in treated rats. The blood flow of ischemic hind limb is expressed as a relative amount compared with the uninjured limb. *P < .005 vs HLI + vehicle. B, Percentage of blood flow vs animals undergoing sham operations (sham HLI) evaluated by laser Doppler at 7, 14, and 21 days after hind limb ischemia. Rats were administered the vehicle or intraperitoneal PDRN (2, 4, 8, and 16 mg/kg daily) starting immediately after surgery. PDRN (8 and 16 mg/kg) restored blood flow in treated animals. *P < .005 vs HLI + vehicle. C, Blood flow evaluated by laser Doppler at day 21 after HLI in the experimental groups. The blood flow of ischemic hind limb was expressed as a relative amount compared with the uninjured limb. *P < .005 vs HLI + vehicle. Error bars in the panels represent the standard deviation. DMPX, 3,7-dimethyl-1-propargilxanthine. Journal of Vascular Surgery 2008 48, 1292-1300DOI: (10.1016/j.jvs.2008.06.041) Copyright © 2008 The Society for Vascular Surgery Terms and Conditions

Fig 2 Laser Doppler images at (Row A) 10 minutes, and at (Row B) 7, (Row C) 14, and (Row D) 21 days after hind limb ischemia (HLI). Polydeoxyribonucleotide (PDRN), at 8 mg/kg, restored blood flow in treated animals. DMPX, 3,7-dimethyl-1-propargilxanthine. Journal of Vascular Surgery 2008 48, 1292-1300DOI: (10.1016/j.jvs.2008.06.041) Copyright © 2008 The Society for Vascular Surgery Terms and Conditions

Fig 3 A, Western blots for vascular endothelial growth factor (VEGF) at 7, 14, and 21 days after hind limb ischemia (HLI).Upper panel, Representative autoradiography highlighting VEGF expression. Lower panel, quantitative data representing the mean ± SD of seven experiments. *P < .005 and #P < .0001 vs HLI + vehicle. B, Expression of messenger RNA for VEGF at 7, 14, and 21 days after HLI. Bars represent the mean ± SD of seven experiments. *P < .005 and #P < .0001 vs HLI + vehicle. DMPX, 3,7-dimethyl-1-propargilxanthine; PDRN polydeoxyribonucleotide. Journal of Vascular Surgery 2008 48, 1292-1300DOI: (10.1016/j.jvs.2008.06.041) Copyright © 2008 The Society for Vascular Surgery Terms and Conditions

Fig 4 Histologic evaluation of adductor muscles after hind limb ischemia (HLI) at day 21 (original magnification ×20). A, Sham HLI animal adductor muscle showing normal muscular architecture. B, HLI animal adductor muscle showing edema with marked cellular infiltration and necrosis. C, Adductor muscle from HLI rats treated with intraperitoneal polydeoxyribonucleotide (PDRN), at 8-mg/kg daily, showing reduced edema and cellular infiltration with no sign of necrosis. D, The means ± SD of the histologic score obtained from seven animals. *P < .005 vs HLI + vehicle. E, Tissue edema evaluated in adductor muscles at day 7 after ischemia. PDRN (8 mg/kg) diminished the degree of edema in treated animals. *P < .005 vs HLI + vehicle. F, Malondialdehyde levels evaluated in adductor muscles of both legs at day 7 after ischemia. PDRN diminished the degree of edema in treated animals. #P < .05 vs HLI. DMPX, 3,7-dimethyl-1-propargilxanthine. Journal of Vascular Surgery 2008 48, 1292-1300DOI: (10.1016/j.jvs.2008.06.041) Copyright © 2008 The Society for Vascular Surgery Terms and Conditions

Fig 5 Immunohistologic evaluation of adductor muscles after hind limb ischemia (HLI) at day 14 (original magnification ×40). A, Adductor muscle from HLI animal stained with platelet-endothelial cell adhesion molecule 1 (PECAM-1). Arrowhead shows very slight positive capillary between muscle fibers. B, Adductor muscle from HLI animal treated with polydeoxyribonucleotide (PDRN; 8 mg/kg) stained with PECAM-1. Arrowheads show positive capillaries between muscle fibers. *P < .005 vs HLI + vehicle. C, The mean ± SD number of capillaries/mm2 are presented; each bar is the mean of seven animals. *P < .005 vs HLI + vehicle. D, Adductor muscle from HLI animal stained with vascular endothelial growth factor (VEGF). Arrowheads show positive cells between muscle fibers. E, Adductor muscle from HLI animal treated with PDRN (8 mg/kg) stained with VEGF. Arrowheads show positive cells between muscle fibers. Journal of Vascular Surgery 2008 48, 1292-1300DOI: (10.1016/j.jvs.2008.06.041) Copyright © 2008 The Society for Vascular Surgery Terms and Conditions